The largest database of trusted experimental protocols

12 protocols using anti il 4 11b11

1

Multiomics analysis of immune responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
At sacrifice, BALF cells, lung, and CNS tissue were collected and prepared as previously described (Kim et al., 2019 (link); Nguyen et al., 2019 (link)). Briefly, the cells were stained with anti-CD4 (RM4–5, BioLegend), anti-Ly6G (1A8, BD Biosciences), and anti-Siglec-F (1RNM44N, eBioscience) mAbs. For intracellular staining, cells were stained with anti-IL-4 (11B11, eBioscience), anti-IL-13 (eBio13A, eBioscience), anti-IL-17 (TC11–18H10, BD Bioscience), anti-IFN-γ (XMG1.2, BD Bioscience), anti-IL-5 (TRFK5, BD Biosciences), anti-IL-10 (JES5–16E3, BD Biosciences) and anti-IL-2 (JES6–5H4, BD Biosciences) mAbs. Cells were acquired using a FACSLSRII or FACSFortessa X-20 (BD Biosciences) and analyzed using a FlowJo software (Tree Star Inc.). For intracellular staining, cells were harvested separately and stimulated ex vivo with PMA (10ng/mL, Millipore-Sigma) and ionomycin (1 μM, Millipore-Sigma) for 4 h in the presence of 2 μM monensin (Calbiochem) during the last 2 h of stimulation. Cells were immediately fixed with 4% paraformaldehyde, permeabilized, and stained with fluorescence-conjugated mAbs.
+ Open protocol
+ Expand
2

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
FITC- or Pacific Blue-conjugated anti-mouse CD4 (GK1.5), Brilliant Violet 510™-conjugated anti-mouse CD4 (MR4-5), APC-conjugated anti-mouse CD45.1 (A20), FITC-conjugated anti-mouse TNF-α (MP6-XT22), APC-conjugated anti-mouse CTLA4 (UC10-4B9), and APC-conjugated anti-mouse GITR (DTA-1) antibodies were purchased from Biolegend. PE-conjugated, APC-conjugated, or Pacific Blue-conjugated anti-mouse Foxp3 antibodies (FJK-16S); PerCP-Cy5.5-conjugated anti-mouse CD45.1 (A20), PE-conjugated anti-mouse PD-1(J43), FITC-conjugated anti-mouse Ki67 (SolA15), APC-conjugated anti-mouse IFN-γ (XMG1.2), anti-IFN-γ (R4-6A2), and anti-IL-4 (11B11) antibodies were purchased from eBioscience. Alexa Fluor 647 Mouse anti-STAT5 (pY694) and PE-conjugated anti-STAT3 (pY705) antibodies were purchased from BD bioscience. Anti-Phospho SMAD3 (phosphor S423+425′ EP823Y) and anti-SMAD3 (AF9F7) antibodies were purchased from Abcam. Anti-GAPDH (14C10) antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA).
+ Open protocol
+ Expand
3

T cell activation and Th1 polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
For early activation markers, cells were incubated for 24h on plate-bound anti-CD3e (10 mg/ml) and anlalyzed by flow citometry. For phosphorylated molecules downstream of TCR vs isotype-matched control antibody, sorted lymph node cells were stimulated for 5 min with soluble anti-CD3ε (10 μg/ml) then fixed 30min at 4°C and permeabilized with the Foxp3/Transcription Factor Staining Buffer set (eBioscience) in the presence of anti CD16/CD32 Fc Block (93) (eBioscience) for 30min at room temperature, and finally incubated for 1h at room temperature with identified above anti-p-ERK Abs in permeabilization buffer. For Th1 polarization CD4+ αβ T cells were isolated by flow cytometry and incubated for 4 days on plate-bound anti-CD3ε and anti-CD28 (5ng/ml each). When indicated (Th1 cocktail), the following cytokines and neutralizing antibody were added to the culture milieu: IL-2 (10 ng/ml; Preprotech), IL-12 (50 ng/ml; Preprotech) and anti-IL-4 (11B11) (10 μg/mL; eBiosciences).
+ Open protocol
+ Expand
4

Naive CD4+ T Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive CD4+ T (CD44lowCD62LhighCD25) cells were purified using a CD4+ naive T cell negative isolation kit according to the manufacturer's protocol (STEMCELL Technologies). The in vitro differentiation experiments were performed as previously described. Naive CD4+ T cells were stimulated with immobilized anti-CD3 (5 μg/ml; 145-2C11; eBioscience) and anti-CD28 (5 μg/ml; 37.51; eBioscience) for 2 days. Then, the cells were washed and transferred to a new plate and further expanded in medium with hIL-2 (50 U/ml, R&D Systems) for 2 days. For Tfh-like cell differentiation, naive CD4+ T cells were activated with anti-CD3 and anti-CD28 as above and treated with 20 ng/ml IL-6 (R&D Systems), 20 ng/ml IL-21 (R&D Systems), 10 μg/ml anti-IL-4 (11B11, eBioscience), 10 μg/ml anti-IFN-γ (XMG1.2, eBioscience), and 20 μg/ml anti-TGF-β (1D11, R&D Systems) for 4 days.
+ Open protocol
+ Expand
5

T cell activation and Th1 polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
For early activation markers, cells were incubated for 24h on plate-bound anti-CD3e (10 mg/ml) and anlalyzed by flow citometry. For phosphorylated molecules downstream of TCR vs isotype-matched control antibody, sorted lymph node cells were stimulated for 5 min with soluble anti-CD3ε (10 μg/ml) then fixed 30min at 4°C and permeabilized with the Foxp3/Transcription Factor Staining Buffer set (eBioscience) in the presence of anti CD16/CD32 Fc Block (93) (eBioscience) for 30min at room temperature, and finally incubated for 1h at room temperature with identified above anti-p-ERK Abs in permeabilization buffer. For Th1 polarization CD4+ αβ T cells were isolated by flow cytometry and incubated for 4 days on plate-bound anti-CD3ε and anti-CD28 (5ng/ml each). When indicated (Th1 cocktail), the following cytokines and neutralizing antibody were added to the culture milieu: IL-2 (10 ng/ml; Preprotech), IL-12 (50 ng/ml; Preprotech) and anti-IL-4 (11B11) (10 μg/mL; eBiosciences).
+ Open protocol
+ Expand
6

Polarization of Naive CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cells were cultured (3x105 cells/well) in 96-well plates coated with anti-CD3 mAb (5 μg/ml) and soluble anti-CD28 mAb (1 μg/ml) and kept in presence of IL-2 (100 U/ml). For TH0 conditions anti-IL-4 (10 μg/ml) and anti-IFN-γ (10 μg/ml) mAb were added. Cultures were supplemented with IL-12 (10 ng/ml) and anti-IL-4 mAb (10 μg/ml) for TH1 polarization; with IL-4 (20 ng/ml), anti-IFN-γ (20 μg/ml) and anti-IL-12 (10 μg/ml) for TH2 polarization; and with TGF-β1 (5 ng/ml), anti-IFN-γ, anti-IL-4 mAb and anti-IL-12 (all 10 μg/ml) for induced Treg polarization. Sorted Treg cells were activated for 48h with anti-CD3 mAb (5 μg/ml) and soluble anti-CD28 mAb (1 μg/ml) plus IL-2 (100 U/ml) and then cultured with IL-4 (10 ng/ml), IL-13 (10 ng/ml) and IL-2 (100 U/ml) for 5 days. All cytokines were from R&D Systems. Anti-CD3 (145-2C11), anti-CD28 (37.51), anti-IFN-γ (XMG1.2), anti-IL-12 (C17.8) and anti-IL-4 (11B11) mAb were from eBioscience. Cells were cultured in RPMI-1640 Medium, 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml of Penicillin/Streptomycin, and 0.05 mM 2-mercaptoethanol.
+ Open protocol
+ Expand
7

Th1 Polarization of 5CC7 and OT-II T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens were harvested from 5CC7 TCR or OT-II transgenic mice. Red blood cells were removed by hypotonic lysis. Cells were suspended in complete RPMI 1640 medium (Gibco ®, Waltham, MA), supplemented as previously described [53 (link)]. For polarization to Th1, 5CC7 spleen cells were incubated with 0.1 μM moth cytochrome C peptide [ANERADLIAYLKQATK] and 10 μg/ml anti-IL-4 (11B11 [eBioscience]) for four days. OT-II spleen cells were incubated with 1 μM Ova 323-339 peptide (AnaSpec, Fremont, CA) and 10 μg/ml anti-IL-4 for four days. Th1 cells were confirmed based on production of IFNγ and absence of IL-4 by intracellular cytokine staining.
+ Open protocol
+ Expand
8

Intracellular Staining and Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
For measurement of transcription factors, cells were fixed and permeabilized with the Foxp3/Transcription Factor Staining Buffer Set (eBioscience) according to the manufacturer’s instructions and then stained with monoclonal antibodies specific for FoxP3 (FJK-16s; eBioscience), Ki67 (SolA15; eBioscience), and HIF1α (241812; R&D Systems). For intracellular staining for cytokines, cells were stimulated with 50 ng/ml phorbol 12-myristate 13-acetate (Sigma) and 500 ng/ml ionomycin (Sigma) in the presence of GolgiStop (BD Biosciences) in complete media for 4 h at 37°C. After surface marker staining, cells were fixed and permeabilized with the Cytofix/Cytoperm kit (BD Biosciences) and then stained with anti-IFNγ (XMG1.2; eBioscience), anti–IL-4 (11B11; eBioscience), anti–IL-5 (TRFK5), and anti–IL-13 (eBio13A; eBioscience) antibodies. Antibodies were from BioLegend unless otherwise stated. An LSR Fortessa (BD Biosciences) was used for multiparameter analysis, and data were analyzed with FlowJo software (TreeStar).
+ Open protocol
+ Expand
9

Measuring Cytokine Responses to αGal-Cer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected intravenously with either 2 μg αGal-Cer (Abcam) or PBS, and harvested 2 h later for detection of IL-4 and IFNγ by flow cytometry and serum IL-4. For serum detection of IFNγ, mice were harvested 16 h following αGal-Cer injection. Anti-IL-4 (11B11, eBioscience, cat. no.: 17-7041-82, 1:100) and anti-IFNγ (XMG1.2, BioLegend, cat. no.: 505813, 1:100) antibodies were used in conjunction with a Cytofix/Cytoperm Kit (Becton Dickinson).
+ Open protocol
+ Expand
10

Th17 Cell Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stimulatory anti-CD3 (2C11) and anti-CD28 (37.51), as well as neutralizing anti-IFN-γ (XMG1.2), anti-IL-2 (JES6-1A12), anti-IL-12p40 (C17.8), and anti-IL-4 (11B11) were from eBioscience. For differentiation, recombinant cytokines were used: TGF-beta (R&D systems), mouse IL-6 and IL-12 (eBioscience). For flow cytometry analysis, surface and intracellular staining antibodies were purchased from eBioscience and Cell Signaling Technologies. For immunoblotting, rabbit antibodies specific for total and phosphorylated forms were obtained from Cell Signaling Technologies: AKT (#2965, #9267, #4058, #4685), rS6 (#4838, #2215, #2211), S6K (#9205, #2708), pCAD (#12662). For imaging, anti-Mouse RORγt (B2D) from eBioscience was used.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!